Trident Texofab Ltd. · BSE:TTFL

Trident Texofab — Q3 FY2026 Earnings Presentation

15 slides from Trident Texofab's earnings presentation, Feb 14, 2026

  1. Slide 1: Cover letter to BSE for earnings presentation

    CIN No. t L17120GJ2008P1C054976 Tf,IIo/ENT- T E)(O tr\A GST No. : 24AADCT0381R17Z 24AADCTO381R2ZY TRIDENT TEXOFAB LIMITED Date:14.02.2026 BSE Limited Stock ID: TTFL P. ]. Towers, Scrip Code: 540726 Dalal Street, Fort, Mumbai - 400001. Dear Sir/Ma'am, Sub : Earnings Presentation-Q3 FY2 6. Pursuant to

  2. Slide 2: Q3FY26 Earnings Presentation

    February 2026 B S E : T T F L | B l o o m b e r g : T T F LT D : I N Q3FY26 Earnings Presentation

  3. Slide 3: Introduction

    Introduction Trident Texofab Limited (‘Trident’ or ‘the Company’), is a semi-composite textile manufacturing and trading Company, deals in a plethora of product ranges that include, Home Furnishing, Garments, Suiting, Shirting, Technical Textiles and Fabrics. With the Company adopting its Shifting G

  4. Slide 4: Corporate Portrait

    Corporate Portrait ‘Shifting Wide ~250 Lakh Gears’ Portfolio Meters Transitioning from trading Of finished and semi- Annual manufacturing to profitability-assertive finished products across capacity manufacturing operations multiple categories 1st 3rd Semi- Generation Phase Composite Founder driven

  5. Slide 5: Expansive Product Portfolio

    Expansive Product Portfolio Manufacturing Vertical Trading Vertical Finished Products Semi-Finished Products Home Furnishing Products Clothing Articles ▪ Embroidered Fabrics ▪ Grey Fabrics ▪ Bed Sheets ▪ Scarfs ▪ Digital Printed Fabrics ▪ Contract Manufacturing in ▪ Curtains ▪ Pareos ▪ Bed Sheets Di

  6. Slide 6: Transitioning Business Model

    Transitioning Business Model Manufacturing Trading ▪ Commenced in 2018 with the completion of ▪ Trading was the core business up till FY18, post that 1st Phase of CAPEX and expanded operations the Company has pivoted towards Manufacturing with the completion of 3rd Phase in June 2021. operations. Tr

  7. Slide 7: Improving Revenue Profile

    Improving Revenue Profile Significant shift in sales profile over the last five years, from being a pure trading company to a dominantly-manufacturing company Changing revenue-mix in favour of manufacturing operations augurs well for profitability, to be further extended by increasing CAPEXs in the

  8. Slide 8: 1st Phase of CAPEX

    1 Phase st of CAPEX Manufacturing Capacities The 1st Phase of CAPEX begun in September 2018 Waterjet Embroidery Unit Unit In the 1st phase the company invested in: ~22 Lakh 37 Lakh ▪ Waterjet Unit Meters/Month Stitches/Day ▪ Value-added Contract Manufacturing – Embroidery & Digital Printing Unit Dig

  9. Slide 9: Shifting Gears

    Shifting Gears The company had completed 2nd Phase of CAPEX by commissioning its Rapier Unit. The company had executed the 3rd Phase of CAPEX in June 2021, at its Hojiwala Facility in Sachin, leading to a capacity augmentation of Waterjet Unit from 8-9 lakh meters/month to 20-22 lakh meters/month. E

  10. Slide 10: Quarterly P&L Highlights

    Quarterly P&L Highlights Q3FY26 Profit and Loss Summary (In ₹ Lakhs) Particulars Q3FY26 Q2FY26 Q3FY25 YoY Change (%) Revenue from Operations 2,574.09 3,063.46 3,168.94 -19% Total Income 2,621.95 3,102.56 3,143.23 -17% Total Operating Expense 2,409.59 2,814.75 2,936.70 -18% EBITDA (Excluding OI and E

  11. Slide 11: Annual P&L Highlights

    Annual P&L Highlights Annual Profit and Loss Summary (In ₹ Lakhs) Particulars FY25 FY24 FY23 FY22 Revenue from Operations 12,205.62 9,948.34 9,635.63 8,429.30 Total Income 12,535.75 9,987.18 9,825.98 8,503.43 Total Operating Expense 11,658.42 9,332.77 9,017.83 7,946.51 EBITDA (Excluding OI) 547.20 6

  12. Slide 12: Balance Sheet Highlights

    Balance Sheet Highlights Annual Balance Sheet Summary (In ₹ Lakhs) Particulars FY25 FY24 FY23 FY22 Shareholder’s Fund 4,723.87 1,625.77 1,517.78 1,295.95 Non-Current Liabilities 1,258.70 2,335.93 2,489.49 2,777.99 Current Liabilities 4,074.99 4,228.07 3,723.45 3,024.88 Total 10,057.57 8,189.77 7,730

  13. Slide 13: Management Commentary

    Management Commentary Q3FY26 Result Discussion The Company has reported a Revenue of ₹2,574.09 Lakhs in Q3FY26, and ₹8,445.23 Lakhs in 9MFY26. Operating profitability margins during the quarter came in at 6.39%, with a PAT of ₹57.01 Lakhs. Q3FY26 PAT registered a growth of 90% Continued Focus on YOY

  14. Slide 14: Disclaimer

    Disclaimer No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the d

  15. Slide 15: Get in touch

    Get in touch Rahul Jariwala Company Secretary and Compliance Officer Trident Texofab Limited [email protected] 0261 – 2451274/2451284

Trident Texofab — Q3 FY2026 Earnings Presentation on 6ix